The event involved a spiros that the customer reported the spiros cap disconnected from the iv tubing, microclave, or syringe.The back of the spiros disconnected from the luer lock of a bifuse or a trifuse.The disconnection occurred during administration of cytarabine, and the duration of the infusion was more than 2 hours.There was a report of loss of blood due to the patient line being opened.The environment, the patient, the parent, and the staff member were exposed to the hazardous drug due to the spill.There was patient involvement, but no report of harm.
|
H10: no product samples, videos, or photographs were returned for investigation.A device history review (dhr) lot review could not be conducted because no lot number(s) was/were identified.A probable cause cannot be identified based on the information that has been provided.Additional information in section d10.
|